The global psychoactive substances market outlook study is a comprehensive databook that provides key market data on the global psychoactive substances industry. Some of the prominent players in the market are Alpha-CAT, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc., Cape Bouvard Technologies Pty Ltd, Cyrelian Pty Ltd., Enecta., GD Pharma, GW Pharmaceuticals PLC., MedReleaf Australia, Teewinot Life Sciences, Tilray, Zynerba Pharmaceuticals. The research report on the global psychoactive substances market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.
The purpose of this study is to identify the current market environment for psychoactive substances and to assess the market's potential for growth over the forecast period. The research delves into market factors affecting the psychoactive substances market (drivers, restraints, opportunities, and trends). The current market for psychoactive substances is examined in this report, as well as the market's future trajectory.
The second chapter, market overview, provides an overview of the psychoactive substances market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.
The global psychoactive substances market is extensive, with a detailed description and evaluation of the market. It includes extensive qualitative and quantitative insights into the report that are aligned with our intended customers' goals and objectives.
Attribute | Description |
Base Year | 2022 |
Historical Year | 2019 - 2021 |
Forecast Period | 2023 - 2029 |
Market Value | US$ Million |
Segments Covered |
By Product Type: Stimulants, Cannabinoids, Hallucinogens, Depressants. By Application: Cancer, Neuropathic Disorders, Spasticity. |
Geographies Covered |
North America: U.S., Canada Europe: Germany, U.K., France, Italy, Spain, Russia, and the Rest of Europe Asia Pacific: China, India, Japan, Australia, and the Rest of Asia Pacific The Middle East and Africa: GCC, South Africa, and the Rest of Middle East and Africa Latin America: Brazil, Mexico, and the Rest of Latin America |
Companies | Alpha-CAT, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc., Cape Bouvard Technologies Pty Ltd, Cyrelian Pty Ltd., Enecta., GD Pharma, GW Pharmaceuticals PLC., MedReleaf Australia, Teewinot Life Sciences, Tilray, Zynerba Pharmaceuticals |
The global economy is highly affected by COVID-19. Various sectors in the economy are much affected by this pandemic. The global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the psychoactive substances market. This report is helpful for business and industry practitioners. The study specifically intended to assist in explaining, directing, and understanding the potential of the psychoactive substances markets. The study focuses on providing readers with an understanding of developments in the industry. The report also provides detailed insights on market segments, market forecasts, leading players, market drivers, and inhibitors.
Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments and year-on-year growth projections that enable readers to identify potential market growth areas.
Chapter 4, the regional analysis includes an in-depth analysis of the psychoactive substances market by region. The chapter covers several regions, including North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each year’s growth projections and a global share of value.
Chapter 5, a competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.
Chapter 6, the company profile of the report also covers key industry players working in the psychoactive substances market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.
1. Introduction
2. Market Overview
2.1. Global Psychoactive Substances Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Technology/Product Roadmap
2.5. PEST Analysis
2.6. Market Growth Opportunity Analysis
2.7. Impact of Covid-19 on Psychoactive Substances Market
3. Market Segmentation
3.1. Global Psychoactive Substances Market Analysis (US$ Mn), By Product Type, 2019 - 2029
3.1.1 Stimulants
3.1.2 Cannabinoids
3.1.3 Hallucinogens
3.1.4 Depressants
3.2. Global Psychoactive Substances Market Analysis (US$ Mn), By Application, 2019 - 2029
3.2.1 Cancer
3.2.2 Neuropathic Disorders
3.2.3 Spasticity
4. Regional Analysis
4.1. North America Psychoactive Substances Market Analysis (US$ Mn), 2019 - 2029
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2.Canada
4.1.2.By Product Type
4.1.3.By Application
4.2.Europe Psychoactive Substances Market Analysis (US$ Mn), 2019 - 2029
4.2.1.By Country
4.2.1.1.Germany
4.2.1.2.U.K.
4.2.1.3.France
4.2.1.4.Italy
4.2.1.5.Spain
4.2.1.6.Rest of Europe
4.2.2.By Product Type
4.2.3.By Application
4.3.Asia Pacific Psychoactive Substances Market Analysis (US$ Mn), 2019 - 2029
4.3.1.By Country
4.3.1.1.China
4.3.1.2.Japan
4.3.1.3.India
4.3.1.4.Rest of Asia Pacific
4.3.2.By Product Type
4.3.3.By Application
4.4.Rest of world Psychoactive Substances Market Analysis (US$ Mn), 2019 - 2029
4.4.1. By Region
4.4.1.1. Middle East & Africa
4.4.1.2. Latin America
4.4.2.By Product Type
4.4.3. By Application
5.Company Profiles
5.1 Alpha-CAT
5.2 AusCann Group Holdings Pty Ltd.
5.3 Cannabics Pharmaceuticals Inc.
5.4 Cape Bouvard Technologies Pty Ltd
5.5 Cyrelian Pty Ltd.
5.6 Enecta.
5.7 GD Pharma
5.8 GW Pharmaceuticals PLC.
5.9 MedReleaf Australia
5.10 Teewinot Life Sciences
5.11 Tilray
5.12 Zynerba Pharmaceuticals